Irinotecan Metronomic Chemotherapy (MC) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation
Abstract
Publication Date:
2007
Citation:
Irinotecan Metronomic Chemotherapy (MC) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation / B. G., G. Bocci, B. M. T., F. A., L. F., O. P., A. G., R. Danesi, D.T. M., A. Falcone - In: Proceedings 14th European Cancer Conference (ECCO)[s.l], 2007. (( convegno 14th European Cancer Conference (ECCO) tenutosi a Barcelona, Spain nel 23 - 27 September.
IRIS type:
03 - Contributo in volume
List of contributors:
B. G., G. Bocci, B. M. T., F. A., L. F., O. P., A. G., R. Danesi, D.T. M., A. Falcone
Link to information sheet:
Book title:
Proceedings 14th European Cancer Conference (ECCO)